FIB-4: Difference between revisions
From IDWiki
No edit summary |
m (Text replacement - "<=" to "≤") |
||
| (One intermediate revision by the same user not shown) | |||
| Line 8: | Line 8: | ||
!Interpretation |
!Interpretation |
||
|- |
|- |
||
| |
|≤ 35 |
||
| |
| |
||
|needs alternative fibrosis assessment |
|needs alternative fibrosis assessment |
||
| Line 22: | Line 22: | ||
|advanced fibrosis likely (F3-F4) |
|advanced fibrosis likely (F3-F4) |
||
|- |
|- |
||
| rowspan="3" | |
| rowspan="3" |≥65 |
||
|<2 |
|<2 |
||
|advanced fibrosis excluded |
|advanced fibrosis excluded |
||
Latest revision as of 14:37, 30 September 2022
- Score used to assess stage of fibrosis in hepatitis C for patients over age 35 years
- See MD Calc
Interpretation
| Age | Score | Interpretation |
|---|---|---|
| ≤ 35 | needs alternative fibrosis assessment | |
| 36-64 | <1.3 | advanced fibrosis excluded |
| 1.3-2.67 | needs further investigations | |
| >2.67 | advanced fibrosis likely (F3-F4) | |
| ≥65 | <2 | advanced fibrosis excluded |
| 2-2.67 | needs further investigations | |
| >2.67 | advanced fibrosis likely |
| Score | Approximate Ishak level of fibrosis |
|---|---|
| <1.45 | 0 to 1 (mild) |
| 1.45 to 3.25 | 2 to 3 (mild to moderate) |
| >3.25 | 4 to 6 (moderate to severe) |
